Cancer Research

Eribulin Mesylate Demonstrated Anti-Tumor Activity In Heavily Pretreated Patients With Advanced Breast Cancer

LONDON, May 16 /PRNewswire/--- Phase II Data Presented at ASCO Showed Acceptable Tolerability Profile, with Low Incidence of Grade 3 and 4 Neuropathy ...

Article - Anna Ohlden - May 16 2008 - 1:31am

Everolimus Targets MTOR Protein, Delays Kidney Cancer Progression In Clinical Trials

New data from an international, multicenter Phase III clinical trial has found that the experimental targeted therapy everolimus (RAD001) significantly delays cancer progression in patients with metastatic kidney cancer whose disease had worsened on other ...

Article - News Staff - May 17 2008 - 10:44am

Hormone In Pituitary Gland May Alter A Fertility 'Thermostat', Say Researchers

Changing the sugars attached to a hormone produced in the pituitary gland increased fertility levels in mice nearly 50 percent, a research group at Washington University School of Medicine in St. Louis has found. The change appears to alter a reproductive ...

Article - News Staff - May 17 2008 - 11:06am

CancerSys- Systems Biology Approach Goes From Mathematics To Visible Changes In Liver Cancer

With systems biology methods, CancerSys investigates molecular- and cell-biological processes in the formation of tumors in the liver Systems Biology is a young field with the overall aim of creating a holistic picture of dynamic life processes with regard ...

Article - News Staff - May 18 2008 - 6:14pm

Case Of Kiwi Guinea-Pig Girl 'Poisoned' By Sugar-Free Gum Adds Weight To Zsweet(R) Alternative

DUBLIN, May 19 /PRNewswire/-- A young lady from New Zealand who discovered that chewing sugar-free gum made her seriously ill has bravely agreed to act as a guinea-pig in an experiment in California. Abby Cormack, 26, hopes that the potentially dangerous ...

Article - Anna Ohlden - May 19 2008 - 1:30am

Herbal Medicine Gets A Look In Pancreatic Cancer Treatment

Pancreatic cancer, the fourth-leading cause of cancer death in this country, takes some 34,000 lives a year. It's usually detected after it has already spread and only 4 percent of individuals with pancreatic cancer live for five years after diagnosis ...

Article - News Staff - May 19 2008 - 11:10am

Presentation Of Landmark Clinical Trial Evaluating Endoscopic Treatment For Pre-cancerous Condition Of Esophagus

SAN DIEGO, May 19 /PRNewswire/--- Superiority of Ablation Therapy Using HALO System Demonstrated for Eradicating Barrett's Esophagus and Reducing Risk for Disease Progression ...

Article - Anna Ohlden - May 19 2008 - 12:32pm

Extinct Tasmanian Tiger Gene Gets New Life- Inside A Mouse

Researchers from the University of Melbourne, Australia, and the University of Texas, USA, have extracted genes from the extinct Tasmanian tiger (thylacine), inserted it into a mouse and observed a biological function – this is a world first for the use of ...

Article - News Staff - May 19 2008 - 10:35pm

Study Finds QIAGEN's HPV Test Offers Greater Long-term Protection From Cervical Disease Than The Pap

HILDEN, Germany, May 20 /PRNewswire/--- Research Supports Replacement of Pap with HPV Test as Front-line Screen Long-term data from a study published in the International Journal of Cancer show that women screened only with a human papillomavirus (HPV) DN ...

Article - Anna Ohlden - May 20 2008 - 3:30am

Oncolytics Biotech Inc. Announces Issuance Of 27th U.S. Patent

CALGARY, Canada, May 20 /PRNewswire/-- Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) ("Oncolytics") today announced that it has been granted U.S. Patent 7,374,752 entitled "Reovirus for the Treatment of Cellular Proliferative Disorders.& ...

Article - Anna Ohlden - May 20 2008 - 9:30am